Evidence map›Paper›PMID 37803001›Full record

ArticleNature communications2023

Systematic functional interrogation of SARS-CoV-2 host factors using Perturb-seq.

Sara Sunshine, Andreas S Puschnik, Joseph M Replogle, Matthew T Laurie, Jamin Liu, Beth Shoshana Zha, James K Nuñez, Janie R Byrum, Aidan H McMorrow, Matthew B Frieman and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. A mini-review on perturbation modelling across single-cell omic modalities.Computational and structural biotechnology journal · 2024
    Review
  15. Review
  16. Interactions of SARS-CoV-2 with Human Target Cells-A Metabolic View.International journal of molecular sciences · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Sara SunshineDepartment of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA.
Andreas S PuschnikChan Zuckerberg Biohub, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-9605-9458
Joseph M ReplogleDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0003-1832-919X
Matthew T LaurieDepartment of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA.
Jamin LiuDepartment of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0001-6386-3709
Beth Shoshana ZhaDepartment of Medicine, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-4190-2823
James K NuñezDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.
Janie R ByrumChan Zuckerberg Biohub, San Francisco, San Francisco, CA, USA.
Aidan H McMorrowChan Zuckerberg Biohub, San Francisco, San Francisco, CA, USA.
Matthew B FriemanDepartment of Microbiology and Immunology, Center for Pathogen Research, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-0107-0775
Juliane WinklerDepartment of Cell and Tissue Biology, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-9762-1721
Xiaojie QiuWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Oren S RosenbergDepartment of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-5736-4388
Manuel D LeonettiChan Zuckerberg Biohub, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-4881-405X
Chun Jimmie YeDivision of Rheumatology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0001-6560-3783
Jonathan S WeissmanWhitehead Institute for Biomedical Research, Cambridge, MA, USA. weissman@wi.mit.edu.ORCID 0000-0003-2445-670X
Joseph L DeRisiDepartment of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA. joe@derisilab.ucsf.edu.
Marco Y HeinChan Zuckerberg Biohub, San Francisco, San Francisco, CA, USA. marco.hein@maxperutzlabs.ac.at.ORCID 0000-0002-9490-2261
University of California, San Francisco · USChan Zuckerberg Initiative (United States) · USHoward Hughes Medical Institute · USUniversity of Maryland, Baltimore · US

Funding

Identification and Characterization of the Antiviral Response to RSV Infection: A Single Cell ApproachF31AI150007 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SUNSHINE, SARA · 2020 to 2022
$116k
NIAID NIH HHS F31 AI150007
6 · The paper itself

Abstract

Genomic and proteomic screens have identified numerous host factors of SARS-CoV-2, but efficient delineation of their molecular roles during infection remains a challenge. Here we use Perturb-seq, combining genetic perturbations with a single-cell readout, to investigate how inactivation of host factors changes the course of SARS-CoV-2 infection and the host response in human lung epithelial cells. Our high-dimensional data resolve complex phenotypes such as shifts in the stages of infection and modulations of the interferon response. However, only a small percentage of host factors showed such phenotypes upon perturbation. We further identified the NF-κB inhibitor IκBα (NFKBIA), as well as the translation factors EIF4E2 and EIF4H as strong host dependency factors acting early in infection. Overall, our study provides massively parallel functional characterization of host factors of SARS-CoV-2 and quantitatively defines their roles both in virus-infected and bystander cells.

Indexed as

COVID-19SARS-CoV-2Epithelial CellsHumansLungProteomics

Identifiers

PMID37803001
PMCPMC10558542
OpenAlexW4387408835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.